Bibliography
- COLE ST, BROSCH R, PARKHILL J etal.: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 393(6685):537–544.
- ••Complete sequence and annotation of TBgenome.
- COHN DL, BUSTREO F, RAVIGLIONE MC: Drug-resistant tuberculosis: review of the worlwide situation and the WHO/ IUATLD global surveillance project. International Union Against Tuberculosis and Lung Disease. Clin Infect. Dis. (1997) 24\(Suppl. 1):S121–S130.
- RAMASWAMY S, MUSSER JM: Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. (1998) 79(1):3–29.
- BARRY CE, WILSON M, LEE R, SCHOOLNIK GK: DNA microarrays and combinatorial chemical libraries: tools for the drug discovery pipeline. Int. j Tuberc. Lung Dis. (2000) 4(12, Suppl. 2):5189–5193.
- •Evaluation of the use of microarrays and combinatorial chemistry.
- BESRA GS, BRENNAN PJ: The mycobacterial cell envelope: a target for novel drugs against tuberculosis. I Pharm. Pharmacol (1997) 49\(Suppl. 1):25–30.
- CHOI KH, KREMER L, BESRA GS, ROCK CO: Identification and substrate specificity of beta-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. j Biol. Chem. (2000) 275(36):28201–28207.
- KREMER L, DOVER LG, MOREHOUSE C et al.: Galactan biosynthesis in Mycobacterium tuberculosic identification of a bifunctional UDP-Galactofuranosyl-transferase. j Biol. Chem. (2001) 276(28):26430–26440.
- KREMER L, BESRA GS: Molecular action of antimycobacterial agents and mechanisms of drug resistance in Mycobacterium tuberculosis. Recent Res. Bevel. Antimicrob. Agents & Chemother. (1999) 3:453–470.
- •• A thorough review of anti-TB agents.
- DESSEN A, QUEMARD A, BLANCHARD JS, JACOBS WR, SACCHETTINI JC: Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis Science (1995) 267:1638–1641.
- •Mode of action of isoniazid.
- WAYNE LG, SRAMEK HA: Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. (1994) 38(9):2054–2058.
- STOVER CK, WARRENER P, VAN DEVANTER DR et al.: A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature (2000) 405(6789)962–966.
- COLDITZ GA, BREWER TF, BERKEY CS et al.: Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA (1994) 271(9):698–702.
- •Analysis of an inhibitor which targets dormant bacffii.
- HUYGEN K, CONTENT J, DENTS 0 et al.: Immunogenecity and protective efficacy of a tuberculosis DNA vaccine. Nature Med. (1996) 2(8):893–898.
- BRANDT L, ELHAY M, ROSENKRANDS I, LINBLAD EB, ANDERSEN P: ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. 1171171L117. (2000) 68(2):791–795.
- HORWITZ MA, HARTH G, DILLON BJ, MASLESA-GALIC' S: Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl Acad. Sci. USA (2000) 97 (25):13853–13858.
- MURRAY PJ, ALDOVINI A, YOUNG RA: Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines. Proc. Nati Acad. Sci. USA (1996) 93(2):934–939.
- HESS J, MIKO D, CATIC A, LEHMENSIEK V, RUSSELL DG, KAUFMANN, SH: Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria morrocytogerres. Proc. Natl. Acad. Sci. USA (1998) 95(9):5299–5304.
- ABOU-ZEID C, GARES MP, INWALD Jet al.: Induction of a Type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect. Immurr. (1997) 65(5):1856–1862.
- GULERIA I, TEITELBAUM R, McADAM RA, KALPANA G, JACOBS WR, BLOOM BR: Auxotrophic vaccines for tuberculosis. Nature Med. (1996) 2(3):334–337.
Websites
- http://www.who.org World health organization: tuberculosis. Fact Sheet No. 104 (2000).